{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:23:35Z","timestamp":1784903015220,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1F30HD104480-01A1"],"award-info":[{"award-number":["1F30HD104480-01A1"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ymgme.2024.108597","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T03:17:43Z","timestamp":1730258263000},"page":"108597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Progressive liver disease and dysregulated glycogen metabolism in murine GSD IX \u03b32 models human disease"],"prefix":"10.1016","volume":"143","author":[{"given":"Rebecca A.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Jeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarav","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajur","family":"Sriraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeksha","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Asokan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-A","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgme.2024.108597_bb0005","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41436-018-0364-2","article-title":"Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"21","author":"Kishnani","year":"2019","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108597_bb0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1196-337","article-title":"Mutations in the testis\/liver isoform of the phosphorylase kinase gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans","volume":"14","author":"Maichele","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2024.108597_bb0015","series-title":"GeneReviews((R)). Seattle (WA)","author":"Herbert","year":"1993"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108597_bb0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgme.2020.10.004","article-title":"Benign or not benign? Deep phenotyping of liver glycogen storage disease IX","volume":"131","author":"Fernandes","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108597_bb0025","series-title":"Nutrition Management of Inherited Metabolic Diseases: Lessons from Metabolic University","author":"Bernstein","year":"2022"},{"key":"10.1016\/j.ymgme.2024.108597_bb0030","doi-asserted-by":"crossref","first-page":"D618","DOI":"10.2741\/Brushia","article-title":"Phosphorylase kinase: the complexity of its regulation is reflected in the complexity of its structure","volume":"4","author":"Brushia","year":"1999","journal-title":"Front. Biosci."},{"issue":"24","key":"10.1016\/j.ymgme.2024.108597_bb0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.21037\/atm.2018.10.59","article-title":"Glycogen metabolism and glycogen storage disorders","volume":"6","author":"Kanungo","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymgme.2024.108597_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbacli.2016.02.001","article-title":"Glycogen metabolism in humans","volume":"5","author":"Adeva-Andany","year":"2016","journal-title":"BBA Clin."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108597_bb0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0969-2126(01)00180-0","article-title":"Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product","volume":"3","author":"Owen","year":"1995","journal-title":"Structure"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108597_bb0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF02106291","article-title":"The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients","volume":"149","author":"Willems","year":"1990","journal-title":"Eur. J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108597_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.str.2008.10.013","article-title":"The structure of phosphorylase kinase holoenzyme at 9.9 angstroms resolution and location of the catalytic subunit and the substrate glycogen phosphorylase","volume":"17","author":"Venien-Bryan","year":"2009","journal-title":"Structure"},{"issue":"44","key":"10.1016\/j.ymgme.2024.108597_bb0060","doi-asserted-by":"crossref","first-page":"14718","DOI":"10.1021\/bi991454f","article-title":"Catalytic mechanism of phosphorylase kinase probed by mutational studies","volume":"38","author":"Skamnaki","year":"1999","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108597_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1515\/jpem-2017-0170","article-title":"PHKG2 mutation spectrum in glycogen storage disease type IXc: a case report and review of the literature","volume":"31","author":"Li","year":"2018","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108597_bb0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/jmg.37.5.376","article-title":"Phosphorylase kinase deficient liver glycogenosis: progression to cirrhosis in infancy associated with PHKG2 mutations (H144Y and L225R)","volume":"37","author":"Burwinkel","year":"2000","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108597_bb0075","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00431-013-2223-0","article-title":"Novel PHKG2 mutation causing GSD IX with prominent liver disease: report of three cases and review of literature","volume":"173","author":"Albash","year":"2014","journal-title":"Eur. J. Pediatr."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2024.108597_bb0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2007.06.007","article-title":"Glycogen storage disease type IX: high variability in clinical phenotype","volume":"92","author":"Beauchamp","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108597_bb0085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.dld.2020.04.017","article-title":"Liver histology in children with glycogen storage disorders type VI and IX","volume":"53","author":"Degrassi","year":"2021","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108597_bb0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41439-021-00172-8","article-title":"A female patient with GSD IXc developing multiple and recurrent hepatocellular carcinoma: a case report and literature review","volume":"8","author":"Kido","year":"2021","journal-title":"Hum. Genome Var."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108597_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2021.05.008","article-title":"Characterization of liver GSD IX gamma 2 pathophysiology in a novel Phkg2(\u2212\/\u2212) mouse model","volume":"133","author":"Gibson","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108597_bb0100","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/s41436-020-0878-2","article-title":"The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases","volume":"22","author":"Heiner-Fokkema","year":"2020","journal-title":"Genet. Med."},{"issue":"17","key":"10.1016\/j.ymgme.2024.108597_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179944","article-title":"A mouse model of glycogen storage disease type IX-Beta: a role for Phkb in Glycogenolysis","volume":"23","author":"Arends","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108597_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2013.12.008","article-title":"Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene","volume":"111","author":"Bali","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108597_bb0115","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108597_bb0120","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41436-019-0561-7","article-title":"Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring","volume":"21","author":"Halaby","year":"2019","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108597_bb0125","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108597_bb0130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of Chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108597_bb0135","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108597_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver-biopsy interpretation in patients with chronic hepatitis-C","volume":"20","author":"Bedossa","year":"1994","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.ymgme.2024.108597_bb0145","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152970","article-title":"Suppression of pullulanase-induced cytotoxic T cell response with a dual promoter in GSD IIIa mice","volume":"7","author":"Lim","year":"2022","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108597_bb0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgme.2017.02.011","article-title":"AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice","volume":"120","author":"Wang","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108597_bb0155","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/hep4.1426","article-title":"Liver glycogen phosphorylase deficiency leads to Profibrogenic phenotype in a murine model of glycogen storage disease type VI","volume":"3","author":"Wilson","year":"2019","journal-title":"Hepatol. Commun."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108597_bb0160","first-page":"804","article-title":"Characterization of a canine model of glycogen storage disease type IIIa","volume":"5","author":"Yi","year":"2012","journal-title":"Dis. Model. Mech."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108597_bb0165","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ymgme.2014.02.005","article-title":"Mouse model of glycogen storage disease type III","volume":"111","author":"Liu","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108597_bb0170","first-page":"41","article-title":"Natural progression of canine glycogen storage disease type IIIa","volume":"66","author":"Brooks","year":"2016","journal-title":"Comp. Med."},{"issue":"8821","key":"10.1016\/j.ymgme.2024.108597_bb0175","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(92)92234-7","article-title":"Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV","volume":"340","author":"Alberti","year":"1992","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108597_bb0180","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.ymgme.2024.108597_bb0185","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.14309\/ajg.0000000000000388","article-title":"Histologic findings of advanced fibrosis and cirrhosis in patients with nonalcoholic fatty liver disease who have Normal aminotransferase levels","volume":"114","author":"Gawrieh","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108597_bb0190","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jpeds.2013.10.071","article-title":"Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels","volume":"164","author":"Molleston","year":"2014","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108597_bb0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12072-021-10153-2","article-title":"High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B","volume":"15","author":"Duan","year":"2021","journal-title":"Hepatol. Int."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108597_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056181","article-title":"Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease","volume":"8","author":"Taylor","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108597_bb0205","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s13311-021-01040-7","article-title":"Targeting Gys1 with AAV-SaCas9 decreases pathogenic Polyglucosan bodies and Neuroinflammation in adult Polyglucosan body and Lafora disease mouse models","volume":"18","author":"Gumusgoz","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108597_bb0210","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00109-014-1127-4","article-title":"Correction of glycogen storage disease type III with rapamycin in a canine model","volume":"92","author":"Yi","year":"2014","journal-title":"J. Mol. Med. (Berl)"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108597_bb0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ymgme.2017.11.006","article-title":"Exercising with blocked muscle glycogenolysis: adaptation in the McArdle mouse","volume":"123","author":"Nielsen","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"Pt 3","key":"10.1016\/j.ymgme.2024.108597_bb0220","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1113\/jphysiol.2002.018044","article-title":"Role of 5\u2019AMP-activated protein kinase in glycogen synthase activity and glucose utilization: insights from patients with McArdle\u2019s disease","volume":"541","author":"Nielsen","year":"2002","journal-title":"J. Physiol."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108597_bb0225","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114554","article-title":"Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism","volume":"13","author":"Kakhlon","year":"2021","journal-title":"Embo Mol. Med."},{"issue":"17","key":"10.1016\/j.ymgme.2024.108597_bb0230","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99694","article-title":"Guaiacol as a drug candidate for treating adult polyglucosan body disease","volume":"3","author":"Kakhlon","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2024.108597_bb0235","first-page":"31","article-title":"Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV","volume":"9","author":"Yi","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108597_bb0240","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s13311-022-01218-7","article-title":"AAV-mediated artificial miRNA reduces pathogenic Polyglucosan bodies and Neuroinflammation in adult Polyglucosan body and Lafora disease mouse models","volume":"19","author":"Gumusgoz","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymgme.2024.108597_bb0245","series-title":"5053 - PicoLab\u00ae Rodent Diet","author":"LabDiet","year":"2024"},{"key":"10.1016\/j.ymgme.2024.108597_bb0250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.omtm.2019.01.006","article-title":"Intravenous injection of an AAV-PHP.B vector encoding human acid alpha-glucosidase rescues both muscle and CNS defects in murine Pompe disease","volume":"12","author":"Lim","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108597_bb0255","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1101\/pdb.prot073411","article-title":"Manual hematoxylin and eosin staining of mouse tissue sections","volume":"2014","author":"Cardiff","year":"2014","journal-title":"Cold Spring Harb Protoc"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108597_bb0260","first-page":"37","article-title":"Diurnal variability of glucose tetrasaccharide (Glc(4)) excretion in patients with glycogen storage disease type III","volume":"58","author":"Young","year":"2021","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108597_bb0265","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0003-2697(03)00056-3","article-title":"Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry","volume":"316","author":"Young","year":"2003","journal-title":"Anal. Biochem."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108597_bb0270","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108597_bb0275","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/bj1470023","article-title":"Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency","volume":"147","author":"Lederer","year":"1975","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108597_bb0280","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/bj1590689","article-title":"Human liver glycogen phosphorylase. Kinetic properties and assay in biopsy specimens","volume":"159","author":"Lederer","year":"1976","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108597_bb0285","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0006-291X(83)90354-6","article-title":"Studies of the residual glycogen branching enzyme activity present in human skin fibroblasts from patients with type IV glycogen storage disease","volume":"111","author":"Brown","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108597_bb0290","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ajmg.a.30945","article-title":"Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family","volume":"139A","author":"L\u2019Hermine-Coulomb","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"issue":"7359","key":"10.1016\/j.ymgme.2024.108597_bb0295","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/476152a","article-title":"On the care and use of US lab animals","volume":"476","author":"Garber","year":"2011","journal-title":"Nature"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:41:56Z","timestamp":1778798516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224004815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1096719224004815"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108597","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive liver disease and dysregulated glycogen metabolism in murine GSD IX \u03b32 models human disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108597"}}